| Trial ID: | L3667 |
| Source ID: | NCT05834868
|
| Associated Drug: |
Thdb0206 Injection
|
| Title: |
Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: THDB0206 Injection|DRUG: Insulin Lispro Injection
|
| Outcome Measures: |
Primary: Change in Glycosylated Haemoglobin (HbA1c) After 26 Weeks of Treatment, Week 26 | Secondary: Change From Baseline in 1-hour Postprandial Glucose (PPG) Excursion at Week 26, Week 26|Change From Baseline in 2-hour Postprandial Glucose (PPG) Excursion at Week 26, Week 26
|
| Sponsor/Collaborators: |
Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
805
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-05-06
|
| Completion Date: |
2024-10-31
|
| Results First Posted: |
|
| Last Update Posted: |
2023-04-28
|
| Locations: |
Zhongshan Hospital, Shanghai, China
|
| URL: |
https://clinicaltrials.gov/show/NCT05834868
|
